|
US$279.00 · In stock
Delivery: <= 3 days. True-PDF full-copy in English will be manually translated and delivered via email.
YY/T 0929.3-2023: Liquid filters for medical infusion equipment - Part 3: Test method for determining liquid bacterial retention of 0.22 μm filter
Status: Valid
| Standard ID | Contents [version] | USD | STEP2 | [PDF] delivered in | Standard Title (Description) | Status | PDF |
| YY/T 0929.3-2023 | English | 279 |
Add to Cart
|
3 days [Need to translate]
|
Liquid filters for medical infusion equipment - Part 3: Test method for determining liquid bacterial retention of 0.22 μm filter
| Valid |
YY/T 0929.3-2023
|
PDF similar to YY/T 0929.3-2023
Basic data | Standard ID | YY/T 0929.3-2023 (YY/T0929.3-2023) | | Description (Translated English) | Liquid filters for medical infusion equipment - Part 3: Test method for determining liquid bacterial retention of 0.22 ��m filter | | Sector / Industry | Medical Device & Pharmaceutical Industry Standard (Recommended) | | Classification of Chinese Standard | C31 | | Classification of International Standard | 11.040.20 | | Word Count Estimation | 14,162 | | Date of Issue | 2023-11-22 | | Date of Implementation | 2024-12-01 | | Older Standard (superseded by this standard) | YY/T 0918-2014 | | Issuing agency(ies) | State Drug Administration | | Summary | This standard specifies a test method for evaluating the bacterial retention capacity of liquid filters for infusions with a nominal pore size of 0.22 ��m. This standard is applicable to the evaluation of the liquid bacterial retention capacity of medicinal solution filters for infusion with a nominal pore size of 0.22 ��m. The evaluation of the liquid bacterial retention capacity of medicinal solution filtration membrane materials for infusion can refer to this standard. This standard is not applicable to the verification of the bacterial retention ability of 0.22 ��m medicinal liquid filters for infusion on specific types of pharmaceuticals. This verification should be conducted using specific medicinal solutions or alternative solutions under simulated actual clinical infusion conditions. | YY/T 0929.3-2023: Liquid filters for medical infusion equipment - Part 3: Test method for determining liquid bacterial retention of 0.22 μm filter
---This is a DRAFT version for illustration, not a final translation. Full copy of true-PDF in English version (including equations, symbols, images, flow-chart, tables, and figures etc.) will be manually/carefully translated upon your order.
ICS 11.040.20
CCSC31
Pharmaceutical Industry Standards of the People's Republic of China
Replaces YY/T 0918-2014
Liquid filters for infusion - Part 3.
Nominal pore size 0.22μm liquid medicine filter
Liquid Bacteria Retention Test Method
Released on 2023-11-22
2024-12-01 implementation
The State Drug Administration issued
Table of Contents
Preface III
Introduction IV
1 Scope 1
2 Normative references 1
3 Terms and Definitions 1
4 Overview 1
5 Test instruments 1
6 Reagents and Materials 2
6.1 Saline Lactose Broth (SLB) 2
6.2 Nutrient agar or tryptic soy agar (NA or TSA) 2
6.3 Nutrient broth or tryptic soy broth (NB or TSB) 2
6.4 Peptone water (1g/L) 3
6.5 0.9% sterile sodium chloride solution 3
6.6 Brevundimonas diminuta (ATCC19146) 3
6.7 Analytical Filters 3
7 Preparation of challenge stock solution and challenge suspension 3
7.1 Preparation of challenge stock solution 3
7.2 Challenge suspension preparation 3
8 Challenge Test 3
8.1 Test sample group 3
8.2 Positive Control Group 4
8.3 Blank control group 4
8.4 Negative Control Group 4
9 Confirmation of test validity 4
10 Result characterization and judgment 4
10.1 Calculate and report the log reduction value (LRV) 4
10.2 Result determination 4
11 Test Report 4
11.1 Identification of the filter to be tested 4
11.2 Challenge test parameters 5
11.3 Test results 5
Appendix A (Informative) Identification Method of Brevundimonas diminuta (ATCC19146) 6
A.1 Overview 6
A.2 Colony morphology 6
A.3 Microscopic observation 6
A.4 Biochemical characteristics test 6
A.5 Bacterial proteomics identification technology 7
References 8
Foreword
This document is in accordance with the provisions of GB/T 1.1-2020 "Guidelines for standardization work Part 1.Structure and drafting rules for standardization documents"
Drafting.
This document is part 3 of YY/T 0929 “Medical Liquid Filters for Infusion”. YY/T 0929 has been published in the following parts.
--- Part 1.Sterilizing grade filter integrity test method;
--- Part 2.Test method for retention of Candida albicans by liquid filters with a nominal pore size of 1.2 μm;
--- Part 3.Test method for liquid bacterial retention in pharmaceutical liquid filters with a nominal pore size of 0.22 μm.
This document replaces YY/T 0918-2014 "Test Method for Bacterial Retention of Filter Membranes and Filters for Pharmaceutical Liquids" and is compatible with YY/T 0918-
Compared with.2014, in addition to structural adjustments and editorial changes, the main technical changes are as follows.
a) The preparation methods of challenge stock solution and challenge suspension were changed, and the preparation of frozen bacterial paste of Brevundimonas diminuta and the preparation of challenge suspension with the same were deleted.
Test method for the original solution (see 7.1, 7.2, 9.4, 9.5 of YY/T 0918-2014);
b) The test parameters such as challenge volume have been changed (see 8.1.2, 13.2 of YY/T 0918-2014);
c) Added blank control group test (see 8.3);
d) The round-robin test scheme was deleted (see Appendix A of YY/T 0918-2014);
e) The content of strain identification was changed and adjusted to the informative appendix (see Appendix A, Chapter 10 of YY/T 0918-2014).
Please note that some of the contents of this document may involve patents. The issuing organization of this document does not assume the responsibility for identifying patents.
This document is proposed by the State Food and Drug Administration.
This document is under the jurisdiction of the National Technical Committee for Standardization of Medical Infusion Equipment (SAC/TC106).
This document was drafted by. Shandong Medical Device and Pharmaceutical Packaging Inspection Institute, Hangzhou Annuo Filter Equipment Co., Ltd., Shandong Zhongbao
Kang Medical Equipment Co., Ltd., Wuhan Zhixun Chuangyuan Technology Development Co., Ltd., and Fresenius Kabi (China) Investment Co., Ltd.
The main drafters of this document are. Wang Wenqing, Guo Xianhu, Zhou Yiqing, Xu Junfeng, Wu Qiyu, Hong Mei, and Fang Liangyan.
Introduction
Although clinical large infusion and infusion equipment have been sterilized, sometimes due to poor infusion environment, improper human operation, infusion equipment
Due to factors such as uneven quality, there is still a risk of microorganisms entering the infusion system. At the same time, some infusion solutions (such as complete nutrient mixtures) have their own
It is conducive to the survival or rapid proliferation of microorganisms. Once contaminated, it is very easy to cause a series of infusion complications.
Its application on infusion equipment can effectively filter out the contaminated microorganisms in the drug solution and the infusion environment, reducing the risk of infusion infection.
The nominal pore size of the filter membrane of the drug filter widely used in infusion equipment is generally above 2μm (the nominal pore size of the common filter membrane is
2μm, 3μm, 5μm, etc.). With the improvement of medical level and awareness of the hazards of infusion, the filter membrane with a nominal pore size of 2μm or less is used clinically.
The number of drug liquid filters is increasing day by day (common filter membrane nominal pore size 0.22μm, 1.2μm, etc.), especially the drug liquid filter with a nominal pore size of 0.22μm.
The filter is a currently recognized sterilization-grade liquid medicine filter that can filter out all common microorganisms that infect infusions.
Bacteria retention capacity is undoubtedly its most critical performance.
This document provides a test method for determining the liquid bacterial retention of sterilizing-grade liquid filters. Usually, only liquid filters that pass this test
The pore size of the filter membrane can be marked as 0.22μm. Sterilizing grade filter membranes can be tested according to this method.
The use of model bacteria to evaluate the liquid bacterial retention capacity of sterilizing-grade liquid filters is different from using other standard substances such as latex particles.
Bacteria are biologically active individuals, which can obtain more intuitive, real and reliable test results. However, its limitation is that the method is relatively complex.
The conventional quality control of liquid medicine filters can be carried out by using the liquid medicine filter method specified in YY/T 0929.1.
Filter integrity test, provided that the specified lower limit of bubble point pressure has been associated with the test method specified in this document.
The correlation method of bacterial retention capacity can be referred to YY/T 1648.
YY/T 0929 “Drug Liquid Filters for Infusion”, currently plans to release the following parts.
--- Part 1.Sterilizing grade filter integrity test method;
--- Part 2.Test method for retention of Candida albicans by liquid filters with a nominal pore size of 1.2 μm;
--- Part 3.Test method for liquid bacterial retention in pharmaceutical liquid filters with a nominal pore size of 0.22 μm.
Liquid filters for infusion - Part 3.
Nominal pore size 0.22μm liquid medicine filter
Liquid Bacteria Retention Test Method
1 Scope
This document describes the test method for the bacterial retention capacity of liquid filters for infusion of pharmaceutical solutions with a nominal pore size of 0.22 μm.
This document is applicable to the evaluation of the liquid bacterial retention capacity of the infusion liquid filter with a nominal pore size of 0.22μm, and the infusion liquid filter membrane
The evaluation of liquid bacteria retention capacity of materials can refer to this document.
This document is not applicable to the verification of the bacterial retention capacity of 0.22μm infusion filter for specific types of drugs.
Specific drug solutions or alternative solutions are administered under conditions that simulate actual clinical infusion conditions.
2 Normative references
The contents of the following documents constitute the essential clauses of this document through normative references in this document.
For referenced documents without a date, only the version corresponding to that date applies to this document; for referenced documents without a date, the latest version (including all amendments) applies to
This document.
GB/T 6682 Specifications and test methods for water used in analytical laboratories
Pharmacopoeia of the People's Republic of China 2020 Edition Volume IV
3 Terms and definitions
The following terms and definitions apply to this document.
3.1
Log reduction value logreduction value; LRV
The logarithm of the ratio of the number of challenge microorganisms to the number of microorganisms in the filtrate to the base 10.
4 Overview
The challenge suspension of Brevundimonas diminuta at a specified challenge level is used to challenge the test solution filter at a specified challenge flow rate.
The filtrate was collected and subjected to microbial analysis to evaluate the bacterial retention capacity of the test solution filter.
5 Test instruments
5.1 Air source or air compressor. can provide clean and stable pressure air source.
5.2 Stainless steel pressure vessel. with a volume of not less than 6L, capable of withstanding a pressure of not less than 350kPa, and easy to be thoroughly cleaned and disinfected.
5.3 Pipes. can be sterilized by pressure steam and can withstand a pressure of not less than 350 kPa.
5.4 Valve. can be sterilized by pressure steam.
5.5 Pressure gauge. can display 0kPa~350kPa pressure.
Tips & Frequently Asked Questions:Question 1: How long will the true-PDF of YY/T 0929.3-2023_English be delivered?Answer: Upon your order, we will start to translate YY/T 0929.3-2023_English as soon as possible, and keep you informed of the progress. The lead time is typically 1 ~ 3 working days. The lengthier the document the longer the lead time. Question 2: Can I share the purchased PDF of YY/T 0929.3-2023_English with my colleagues?Answer: Yes. The purchased PDF of YY/T 0929.3-2023_English will be deemed to be sold to your employer/organization who actually pays for it, including your colleagues and your employer's intranet. Question 3: Does the price include tax/VAT?Answer: Yes. Our tax invoice, downloaded/delivered in 9 seconds, includes all tax/VAT and complies with 100+ countries' tax regulations (tax exempted in 100+ countries) -- See Avoidance of Double Taxation Agreements (DTAs): List of DTAs signed between Singapore and 100+ countriesQuestion 4: Do you accept my currency other than USD?Answer: Yes. If you need your currency to be printed on the invoice, please write an email to [email protected]. In 2 working-hours, we will create a special link for you to pay in any currencies. Otherwise, follow the normal steps: Add to Cart -- Checkout -- Select your currency to pay.
|